Diagnostics stocks surge on Covid scare; Dr. Lal PathLabs, Vijaya Diagnostic rise up to 8%
Among diagnostics companies, Vijaya Diagnostic Centre topped the gainers’ chart, followed by Dr. Lal PathLabs, Metropolis Healthcare, and Thyrocare Technologies.
Building the Metropolis of the future
Ameera Shah's Metropolis Healthcare is all set to acquire Hitech Diagnostics Centre. Here's Fortune India's earlier story on how Shah is transforming her fast-growing pathlab company.
Healthcare leaders shine in MPW 2020 list
Cipla’s Samina Hamied, Lupin’s Vinita Gupta biggest rank gainers from the sector.
Covid-19: Pvt labs augment India’s testing capacity
Private sector diagnostic chains are collaborating with each other to deliver high quality testing services to assist the government in tackling the coronavirus crisis.
‘Going public will help build credibility with stakeholders’
By holding itself accountable to committed results and highest governance standards, Metropolis hopes to attract and retain the support of marquee investors for future growth.
Metropolis Healthcare lists at a premium
The stock opened at ₹960 per share on the BSE, a premium of 9% over its issue price of ₹880.
Metropolis Healthcare IPO to open on April 3
The diagnostics company is looking to raise up to ₹1,200 crore from its listing; the price band of the IPO is fixed at ₹877-₹880 per share
D-Street beckons Metropolis Healthcare
Diagnostics company Metropolis Healthcare has filed an offer document with SEBI for an IPO.
Metropolis Healthcare: Just what the doctor ordered
The diagnostics chain wasn’t running smoothly when Ameera Shah took over as MD. But with smart leadership and the backing of a few private equity investors, she has put the business back on track.
Women entrepreneurs don’t get enough support: Ameera Shah
Ameera Shah, promoter and managing director Metropolis Healthcare, speaks to deputy editor T. Surendar about women entrepreneurship.